Skip to main content

Table 2 Clinical patient characteristics

From: International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26

   Number Percent
Treatment status On treatment 113 36.1
Post treatment 200 63.9
Time since diagnosis [in months] On treatment mean 6.7 SD 17.7
Post treatment mean 5.4 SD 3.4
Histological tumour type Seminoma 162 62.5
Non-Seminoma 97 37.5
Missing 54  
Metastases Metastases Yes 50 18.6
Metastases No 219 81.4
Missing 44  
Recurrence Recurrence Yes 39 14.2
Recurrence No 235 85.8
Missing 39  
Desire for a child No 143 55.6
Yes 114 44.4
Missing 56  
Testicular Implant No 182 75.2
Yes 60 24.8
Missing 71  
On-treatment Group: Surgery Surgery No 14 15.9
Surgery Yes 74 84.1
Missing 25  
On-treatment Group: Chemotherapy Chemotherapy No 13 14.8
Chemotherapy Yes 75 85.2
Missing 25  
Post-treatment Group:
Previous Surgery
Surgery No 9 5.5
Surgery Yes 154 94.5
Missing 37  
Post-treatment Group:
Previous Chemotherapy
Chemotherapy No 60 36.1
Chemotherapy Yes 106 63.9
Missing 34  
Post-treatment Group:
Previous Radiotherapy
Radiotherapy No 157 94.0
Radiotherapy Yes 10 6.0
Missing 33  
  1. Percentages are given for valid cases